Ciomei M - Search Results

1

Bombesin stimulates growth of human prostatic cancer cells in vitro.

Bologna M, Festuccia C, Muzi P, Biordi L, Ciomei M. Bologna M, et al. Among authors: ciomei m. Cancer. 1989 May 1;63(9):1714-20. doi: 10.1002/1097-0142(19900501)63:9<1714::aid-cncr2820630912>3.0.co;2-h. Cancer. 1989. PMID: 2539244

2

Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy.

Albanese C, Alzani R, Amboldi N, Avanzi N, Ballinari D, Brasca MG, Festuccia C, Fiorentini F, Locatelli G, Pastori W, Patton V, Roletto F, Colotta F, Galvani A, Isacchi A, Moll J, Pesenti E, Mercurio C, Ciomei M. Albanese C, et al. Among authors: ciomei m. Mol Cancer Ther. 2010 Aug;9(8):2243-54. doi: 10.1158/1535-7163.MCT-10-0190. Epub 2010 Aug 3. Mol Cancer Ther. 2010. PMID: 20682657

3

In vitro and in vivo activity of alkylating bombesin receptor antagonists on small cell lung carcinoma.

Ciomei M, Pastori W, Pastori A, de Castiglione R, Gozzini L, Corradi F. Ciomei M, et al. Anticancer Res. 1993 Jan-Feb;13(1):75-9. Anticancer Res. 1993. PMID: 8386497

4

Anti-tumour efficacy on glioma models of PHA-848125, a multi-kinase inhibitor able to cross the blood-brain barrier.

Albanese C, Alzani R, Amboldi N, Degrassi A, Festuccia C, Fiorentini F, Gravina G, Mercurio C, Pastori W, Brasca M, Pesenti E, Galvani A, Ciomei M. Albanese C, et al. Among authors: ciomei m. Br J Pharmacol. 2013 May;169(1):156-66. doi: 10.1111/bph.12112. Br J Pharmacol. 2013. PMID: 23347136 Free PMC article.

5

Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).

Ciomei M, Pastori W, Capolongo L, Geroni C, Melegaro G, Pennella G, Grandi M. Ciomei M, et al. Br J Cancer. 1995 Dec;72(6):1504-8. doi: 10.1038/bjc.1995.537. Br J Cancer. 1995. PMID: 8519667 Free PMC article.

6

Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.

Geroni C, Ripamonti M, Arrigoni C, Fiorentini F, Capolongo L, Moneta D, Marchini S, Della Torre P, Albanese C, Lamparelli MG, Ciomei M, Rossi R, Caruso M. Geroni C, et al. Among authors: ciomei m. Cancer Res. 2001 Mar 1;61(5):1983-90. Cancer Res. 2001. PMID: 11280756

7

Bombesin receptor antagonists. 3. Irreversible alkylating analogues: melphalan derivatives.

de Castiglione R, Gozzini L, Galantino M, Corradi F, Arlandini E, Molinari I, Ciomei M. de Castiglione R, et al. Among authors: ciomei m. Farmaco. 1991 Jun;46(6):743-57. Farmaco. 1991. PMID: 1663360

8

Anti-insulin-like growth factor-I activity of a novel polysulphonated distamycin A derivative in human lung cancer cell lines.

de Cupis A, Ciomei M, Pirani P, Ferrera A, Ardizzoni A, Favoni RE. de Cupis A, et al. Among authors: ciomei m. Br J Pharmacol. 1997 Feb;120(3):537-43. doi: 10.1038/sj.bjp.0700937. Br J Pharmacol. 1997. PMID: 9031761 Free PMC article.

9

Bombesin receptor antagonists. 5 new irreversible alkylating analogues.

de Castiglione R, Gozzini L, Galantino M, Corradi F, Ciomei M, Roletto F, Bertolero F. de Castiglione R, et al. Among authors: ciomei m. Farmaco. 1992 Jun;47(6):855-67. Farmaco. 1992. PMID: 1326977

10

Antitumor efficacy of edotecarin as a single agent and in combination with chemotherapy agents in a xenograft model.

Ciomei M, Croci V, Ciavolella A, Ballinari D, Pesenti E. Ciomei M, et al. Clin Cancer Res. 2006 May 1;12(9):2856-61. doi: 10.1158/1078-0432.CCR-05-1859. Clin Cancer Res. 2006. PMID: 16675581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters